ニュージーランドのオーソバイオロジクス市場見通し

◆英語タイトル:New Zealand Orthobiologics Market Outlook to 2022
◆商品コード:GDMECC0161DBOD
◆発行会社(調査会社):GlobalData
◆発行日:2016年9月1日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ニュージーランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,995 ⇒換算¥549,450見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD9,990 ⇒換算¥1,098,900見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD14,985 ⇒換算¥1,648,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

New Zealand Orthobiologics Market Outlook to 2022
Summary

GlobalData’s new report, New Zealand Orthobiologics Market Outlook to 2022, provides key market data on the New Zealand Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments – Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends)

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories – Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the New Zealand Orthobiologics market.
- Key players covered include Medtronic plc, Arthrex, Inc., Sanofi, DePuy Synthes, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, New Zealand 7
3.1 Orthobiologics Market, New Zealand, Revenue ($m), 2008-2015 7
3.2 Orthobiologics Market, New Zealand, Revenue ($m), 2015-2022 9
3.2.1 Bone Grafts and Substitutes Market, New Zealand, Revenue ($m), by Segment, 2008-2015 11
3.2.2 Bone Grafts and Substitutes Market, New Zealand, Revenue ($m), by Segment, 2015-2022 13
3.3 Orthobiologics Market, New Zealand, Volume (Units), 2008-2015 15
3.4 Orthobiologics Market, New Zealand, Volume (Units), 2015-2022 17
3.4.1 Bone Grafts and Substitutes Market, New Zealand, Volume (Units), by Segment, 2008-2015 19
3.4.2 Bone Grafts and Substitutes Market, New Zealand, Volume (Units), by Segment, 2015-2022 21
3.5 Orthobiologics Market, New Zealand, Average Price ($), 2008-2015 23
3.6 Orthobiologics Market, New Zealand, Average Price ($), by Segment 2008-2015 25
3.7 Orthobiologics Market, New Zealand, Distribution Share by Revenue ($m), 2008-2022 27
3.8 Orthobiologics Market, New Zealand, Company Share by Revenue ($m), 2015 28
4 Overview of Key Companies in New Zealand, Orthobiologics Market 30
4.1 Medtronic plc 30
4.1.1 Company Overview 30
4.2 DePuy Synthes, Inc. 30
4.2.1 Company Overview 30
4.3 Seikagaku Corporation 30
4.3.1 Company Overview 30
4.4 Patterson Medical Holdings, Inc. 31
4.4.1 Company Overview 31
4.5 Baxter International Inc. 31
4.5.1 Company Overview 31
4.6 Sanofi 31
4.6.1 Company Overview 31
4.7 Stryker Corporation 32
4.7.1 Company Overview 32
4.8 Zimmer Biomet Holdings, Inc. 32
4.8.1 Company Overview 32
4.9 Arthrex, Inc. 32
4.9.1 Company Overview 32
5 Orthobiologics Market Pipeline Products 34
6 Appendix 37
6.1 Research Methodology 38
6.1.1 Coverage 38
6.1.2 Secondary Research 38
6.1.3 Primary Research 39
6.1.4 Company Share Analysis 39
6.1.5 Distribution Share Analysis 39
6.1.6 Benchmarking 39
6.2 GlobalData Consulting 40
6.3 Contact Us 40
6.4 Disclaimer 41

1.1 List of Tables
Table 1: Orthobiologics Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015 8
Table 2: Orthobiologics Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022 10
Table 3: Bone Grafts and Substitutes Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015 12
Table 4: Bone Grafts and Substitutes Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022 14
Table 5: Orthobiologics Market, New Zealand, Volume (Units), Historic, 2008-2015 16
Table 6: Orthobiologics Market, New Zealand, Volume (Units), Forecast, 2015-2022 18
Table 7: Bone Grafts and Substitutes Market, New Zealand, Volume (Units), Historic, 2008-2015 20
Table 8: Bone Grafts and Substitutes Market, New Zealand, Volume (Units), Forecast, 2015-2022 22
Table 9: Orthobiologics Market, New Zealand, Average Price ($), Historic, 2008-2015 23
Table 10: Orthobiologics Market, New Zealand, Average Price ($), Forecast, 2015-2022 24
Table 11: Orthobiologics Market, New Zealand, Average Price ($) Historic, 2008-2015 25
Table 12: Orthobiologics Market, New Zealand, Average Price ($), Forecast, 2015-2022 26
Table 13: Orthobiologics Market, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2008-2022 27
Table 14: Orthobiologics Market, New Zealand, Company Share by Revenue ($m), USD Constant, 2015 29
Table 15: Orthobiologics Market Pipeline Products 34

1.2 List of Figures
Figure 1: Orthobiologics Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015 7
Figure 2: Orthobiologics Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022 9
Figure 3: Bone Grafts and Substitutes Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015 11
Figure 4: Bone Grafts and Substitutes Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022 13
Figure 5: Orthobiologics Market, New Zealand, Volume (Units), Historic, 2008-2015 15
Figure 6: Orthobiologics Market, New Zealand, Volume (Units), Forecast, 2015-2022 17
Figure 7: Bone Grafts and Substitutes Market, New Zealand, Volume (Units), Historic, 2008-2015 19
Figure 8: Bone Grafts and Substitutes Market, New Zealand, Volume (Units), Forecast, 2015-2022 21
Figure 9: Orthobiologics Market, New Zealand, Company Share (%) 2015 28

★調査レポート[ニュージーランドのオーソバイオロジクス市場見通し]販売に関する免責事項
★調査レポート[ニュージーランドのオーソバイオロジクス市場見通し]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆